- Home
- FF vs ABEO Comparison
FF vs ABEO Comparison
Compare FF & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FF | ABEO |
|---|---|---|
| Founded | N/A | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 212.3M | 307.5M |
| IPO Year | 2005 | 2005 |
Fundamental Metrics
Financial Performance| Metric | FF | ABEO |
|---|---|---|
| Price | $4.16 | $5.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 408.5K | ★ 972.4K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | ★ 5.32% | N/A |
| EPS Growth | N/A | ★ 165.16 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,998,000.00 |
| Revenue This Year | N/A | $1,024.31 |
| Revenue Next Year | N/A | $145.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 258.18 |
| 52 Week Low | $3.09 | $4.00 |
| 52 Week High | $5.12 | $7.54 |
Technical Indicators
Market Signals| Indicator | FF | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 43.74 | 53.82 |
| Support Level | $4.16 | $5.24 |
| Resistance Level | $4.51 | $6.07 |
| Average True Range (ATR) | 0.25 | 0.27 |
| MACD | -0.08 | -0.02 |
| Stochastic Oscillator | 17.95 | 45.33 |
Price Performance
Historical ComparisonAbout FF FutureFuel Corp.
FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuels segment sells biodiesel and other petroleum products, with fuels made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment, which generates the majority of revenue, sells products used in the production of agricultural chemicals, including herbicides, as well as coatings and cleaning products such as detergents.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.